Insider trading · Q3 2026 · CIK 1660334

Verrica Pharmaceuticals Inc. (VRCA) insider trading.

In Q3 2026, insiders at Verrica Pharmaceuticals Inc. reported 6 non-derivative transactions on 4 Forms 3, 4 and 5: 6 open-market purchases worth $211K and 0 sales.

Transactions
6
Purchases (P)
6
Sales (S)
0
Net shares, P minus S
42,230
Insiders
4
Last filed
2026-08-18

Insiders

InsiderRelationshipTransactionsBuysSales
Rosenberg Noah L.Officer · CMO220
Rieger JaysonDirector, Officer · CEO and President220
Kirby John J.Officer · Interim CFO110
Zawitz DavidOfficer · Chief Operating Officer110

Transactions

6 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-08-18Kirby John J.P (A)5,000$4.9323,962Form 4
2026-08-18Rosenberg Noah L.P (A)2,030$4.928,587Form 4
2026-08-17Rosenberg Noah L.P (A)4,200$4.916,557Form 4
2026-08-17Rieger JaysonP (A)5,000$4.91207,593Form 4
2026-08-17Zawitz DavidP (A)6,000$4.9827,000Form 4
2026-08-14Rieger JaysonP (A)20,000$5.06202,593Form 4

Transaction codes in this quarter

Get VRCA insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1660334&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · VRCA company page · Verrica Pharmaceuticals Inc. on SEC.gov

Questions

Are insiders buying or selling Verrica Pharmaceuticals Inc. (VRCA)?

In Q3 2026, insiders at Verrica Pharmaceuticals Inc. reported 6 non-derivative transactions on 4 Forms 3, 4 and 5: 6 open-market purchases worth $211K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Verrica Pharmaceuticals Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/vrca.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.